Andere Sprachen Intra-Cellular Therapies, Inc.

Aktien

A1XDTL

US46116X1019

ITCI

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 26.04.2024			% 5 Tage	% 1. Jan.
73,26 ^USD	+1,57 %		+1,23 %	+2,29 %

23.04.	INTRA-CELLULAR THERAPIES, INC. : Canaccord Genuity bleibt bei seiner Kaufempfehlung	ZM
23.04.	INTRA-CELLULAR THERAPIES, INC. : Needham & Co. bekräftigt seine Kaufempfehlung	ZM

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Intra-Cellular Therapies Announces Closing of $575 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares	24.04.
Intra-Cellular Therapies Prices Public Offering of Common Stock - April 18, 2024	19.04.
Intra-Cellular Therapies Prices $500 Million Stock Offering	18.04.
Intra-Cellular Therapies Prices Public Offering of Common Stock	18.04.
Intra-Cellular Therapies Launches $500 Million Public Offering of Stock; Shares Edge Lower in Late Trade	16.04.
UnitedHealth Group, Morgan Stanley rise; PNC Financial, Live Nation fall, Tuesday, 4/16/2024	16.04.
Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock	16.04.
Sector Update: Health Care Stocks Higher Late Afternoon	16.04.
Top Midday Gainers	16.04.
US Stocks Lacking Direction Prior to Powell Remarks, Investors Looking for Signs of Future Rate Cuts by Federal Reserve	16.04.
Intra-Cellular Therapies Stock Jumps After Major Depressive Disorder Treatment Study Shows Positive Results	16.04.
Intra-Cellular Therapies Announces Positive Phase 3 Topline Results from Study 501 Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder	16.04.
Intra-Cellular Therapies Announces Positive Phase 3 Topline Results from Study 501 Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder	16.04.
Intra-Cellular Therapies CFO Hineline Retiring, Promotes Halstead to President	19.03.
Intra-Cellular Therapies Announces Executive Appointments and Leadership Changes	19.03.
Intra-Cellular Therapies, Inc. Announces Executive Changes	19.03.
Intra-Cellular Therapies, Inc. Announces Retirement of Larry Hineline as Chief Financial Officer	19.03.
Intra-Cellular Therapies to Participate in Three Upcoming Investor Conferences	06.03.
Intra-Cellular Therapies Insider Sold Shares Worth $1,458,650, According to a Recent SEC Filing	29.02.
Intra-Cellular Therapies Insider Sold Shares Worth $1,808,253, According to a Recent SEC Filing	28.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Intra-Cellular Therapies, Inc.

Aktien

A1XDTL

US46116X1019

ITCI

Andere Sprachen

Filter